Downloads: 1
| # | Publication | Year | Samples | Patients | Location | ER status | Menopause status | Age (years) | Treatment | Timepoints |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bownes | 2019 | 95 | 34 | UK | Mixed | Mixed | 29-76 | Chemotherapy | 4:Pre-T,2wk,M,R |
| 2 | Magbanua | 2015 | 248 | 166 | USA | Mixed | Mixed | 26-68 | Chemotherapy | 3:Pre-T,1-3d,R |
| 3 | Park | 2020 | 227 | 136 | Korea | Mixed | Mixed | 24-68 | Chemotherapy | 3:Pre-T,AC,6m/S |
| 4 | Miller | 2010 | 176 | 62 | UK | ER+ | PM | 29-76 | Endocrine | 3:Pre-T,2wk,3m |
| 5 | Arthur | 2014 | 36 | 13 | UK | ER+ | PM | 55-91 | Endocrine | 3:Pre-T,2wk,3m |
| 6 | Turnbull | 2015 | 75 | 25 | UK | ER+ | PM | 55-91 | Endocrine | 3:Pre-T,2wk,3m |
| 7 | Dunbier | 2013 | 179 | 81 | UK | ER+ | PM | 71(±)8.6 | Endocrine | 3:Pre-T,2wk,3m |
| 8 | Ellis | 2017 | 218 | 109 | USA | ER+ | PM | 43-90 | Endocrine | 3:Pre-T,2-4wk/M |
| 9 | Gao | 2018 | 426 | 213 | UK | ER+ | PM | 50-80+ | Endocrine | 2:Pre-T,2wk |
| 10 | Gao | 2020 | 178 | 178 | UK | ER+ | PM | 50-80+ | Endocrine | 2:Pre-T,2wk |
| 11 | Korde | 2010 | 61 | 28 | USA | Mixed | Mixed | 33-75 | Chemotherapy | 3:Pre-T,42d,R |
| 12 | Sabine | 2010 | 88 | 23 | UK | ER+ | PM | 33-75 | Chemotherapy | 2:Pre-T,2wk |
| 13 | Selli-Karakaya | 2019 | 101 | 39 | UK | ER+ | PM | 56-89 | Endocrine | 3:Pre-T,13-120d,>4m |
| 14 | Sammut | 2022 | 168 | 168 | UK | Mixed | Mixed | 28-81 | Chemotherapy | 1:Pre-T |